login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AVALO THERAPEUTICS INC (AVTX) Stock News
USA
- NASDAQ:AVTX -
US05338F3064
-
Common Stock
18.03
USD
0 (-0.03%)
Last: 10/31/2025, 8:27:31 PM
18.03
USD
0 (0%)
After Hours:
10/31/2025, 8:27:31 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AVTX Latest News, Press Relases and Analysis
All
Press Releases
5 days ago - By: Avalo Therapeutics
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
5 days ago - By: Avalo Therapeutics
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
12 days ago - By: Stocktwits
Avalo Therapeutics Stock Rises Premarket Ahead Of Oppenheimer Call On Lead Hidradenitis Drug
a month ago - By: Avalo Therapeutics
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources
a month ago - By: Avalo Therapeutics
Avalo Therapeutics Expands Leadership Team with Key Appointments in Business Development and Human Resources
a month ago - By: Benzinga
- Mentions:
RDHL
CLLS
MRUS
MLTX
...
12 Health Care Stocks Moving In Monday's Pre-Market Session
a month ago - By: Benzinga
- Mentions:
EPOW
ZURA
YAAS
CGC
...
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket
a month ago - By: Avalo Therapeutics
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
a month ago - By: Avalo Therapeutics
Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors
2 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in Upcoming Investor Conferences
2 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in Upcoming Investor Conferences
3 months ago - By: Avalo Therapeutics
Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates
3 months ago - By: Avalo Therapeutics
Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates
4 months ago - By: Yahoo Finance
Avalo Adds Dr. Rita Jain to Board as LOTUS Trial Advances
4 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in Upcoming Investor Conferences
4 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in Upcoming Investor Conferences
5 months ago - By: Avalo Therapeutics
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
5 months ago - By: Avalo Therapeutics
Avalo Therapeutics Announces Appointment of Rita Jain, M.D. to Board of Directors
5 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in Upcoming Investor Conferences
5 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in Upcoming Investor Conferences
6 months ago - By: Avalo Therapeutics
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
6 months ago - By: Avalo Therapeutics
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
6 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
6 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in The Citizens Life Sciences Conference
7 months ago - By: Avalo Therapeutics
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
7 months ago - By: Avalo Therapeutics
- Mentions:
COLL
TRVI
BHVN
Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board
8 months ago - By: Avalo Therapeutics
Avalo Reports 2024 Financial Results and Recent Business Updates
8 months ago - By: Avalo Therapeutics
Avalo Reports 2024 Financial Results and Recent Business Updates
8 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Participate in Upcoming Investor Conferences
9 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
9 months ago - By: Avalo Therapeutics
Avalo Therapeutics to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference
10 months ago - By: Avalo Therapeutics
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
10 months ago - By: Avalo Therapeutics
Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
Please enable JavaScript to continue using this application.